dc.contributor.author |
Joshi M.S. |
|
dc.contributor.author |
Wattanapitayakul S. |
|
dc.contributor.author |
Schanbacher B.L. |
|
dc.contributor.author |
Bauer J.A. |
|
dc.date.accessioned |
2021-04-05T03:34:58Z |
|
dc.date.available |
2021-04-05T03:34:58Z |
|
dc.date.issued |
2011 |
|
dc.identifier.issn |
14791641 |
|
dc.identifier.other |
2-s2.0-80053058309 |
|
dc.identifier.uri |
https://ir.swu.ac.th/jspui/handle/123456789/14467 |
|
dc.identifier.uri |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-80053058309&doi=10.1177%2f1479164111416679&partnerID=40&md5=ef314d3a53012d3c76722432c8a500e2 |
|
dc.description.abstract |
The functional relevance of NOS3 and ACE genetic variations to endothelial cell function is largely unstudied. Here we tested the functional relevance of the NOS3 (Glu298Asp) polymorphism and ACE (I/D) polymorphism in endothelial cells in vitro. Our hypothesis was that these genetic polymorphisms alter endothelial cell sensitivity to glucose and 3-nitrotyrosine (3NT). Genotyped HUVECs were incubated with glucose, free 3NT or a combination of these two toxicants. Significant differences in glucose-induced cell death and free 3NT-induced cell death were observed among the NOS3 genotypes. Combined glucose/3NT caused increased toxicity among the NOS3 genotypes. No differences were observed among the ACE genotypes in their responses to glucose/3NT. These data demonstrate that the NOS3 genotype may be an important predictor of, or be mechanistically involved in, endothelial vulnerability, whereas the ACE I/D genotype is apparently less important. Thus this NOS3 genetic variation may play a role in vulnerability to endothelium-dependent diabetic vascular complications. © SAGE Publications 2011. |
|
dc.subject |
3 nitrotyrosine |
|
dc.subject |
dipeptidyl carboxypeptidase |
|
dc.subject |
endothelial nitric oxide synthase |
|
dc.subject |
glucose |
|
dc.subject |
article |
|
dc.subject |
cell death |
|
dc.subject |
cell viability |
|
dc.subject |
cellular stress response |
|
dc.subject |
genetic polymorphism |
|
dc.subject |
genetic variability |
|
dc.subject |
genotype |
|
dc.subject |
human |
|
dc.subject |
human cell |
|
dc.subject |
human cell culture |
|
dc.subject |
hyperglycemia |
|
dc.subject |
in vitro study |
|
dc.subject |
umbilical vein endothelial cell |
|
dc.subject |
Caveolin 1 |
|
dc.subject |
Cell Death |
|
dc.subject |
Cells, Cultured |
|
dc.subject |
Diabetic Angiopathies |
|
dc.subject |
Genotype |
|
dc.subject |
Glucose |
|
dc.subject |
Human Umbilical Vein Endothelial Cells |
|
dc.subject |
Humans |
|
dc.subject |
Hyperglycemia |
|
dc.subject |
Nitric Oxide Synthase Type III |
|
dc.subject |
Nitrites |
|
dc.subject |
Peptidyl-Dipeptidase A |
|
dc.subject |
Phenotype |
|
dc.subject |
Phosphorylation |
|
dc.subject |
Polymorphism, Genetic |
|
dc.subject |
Proto-Oncogene Proteins c-akt |
|
dc.subject |
Tyrosine |
|
dc.title |
Effects of human endothelial gene polymorphisms on cellular responses to hyperglycaemia: Role of NOS3 (Glu298Asp) and ACE (I/D) polymorphisms |
|
dc.type |
Article |
|
dc.rights.holder |
Scopus |
|
dc.identifier.bibliograpycitation |
Diabetes and Vascular Disease Research. Vol 8, No.4 (2011), p.276-283 |
|
dc.identifier.doi |
10.1177/1479164111416679 |
|